Skip to content

A clinical study of stomach cancer in a tertiary care centre in Chengalpattu district.

A clinicopathological study of carcinoma stomach in a tertiary care centre in Chengalpattu district.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045622
Enrollment
25
Registered
2022-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C169- Malignant neoplasm of stomach, unspecified

Interventions

None listed

Sponsors

Melmaruvathur Adhiparasakthi Institute Of Medical Sciences And Research
Lead Sponsor
Umesh raj
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: patient who belongs to the age group between 20 to 99 years

Exclusion criteria

Exclusion criteria: recurrent carcinoma stomach

Design outcomes

Primary

MeasureTime frame
studying the clinical and pathological outcomes in carcinoma stomachTimepoint: baseline, 2 weeks and 4 weeks

Secondary

MeasureTime frame
response to the treatmentTimepoint: 4 weeks and 8 weeks

Countries

India

Contacts

Public ContactJenith Nivethithan S

Melmaruvathur Adhiparasakthi Institute Of medical Sciences And Research

drumeshraj@gmail.com9894485752

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026